China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Oct 20, 2025, 4:00 PM EDT - Market closed
China SXT Pharmaceuticals Market Cap
China SXT Pharmaceuticals has a market cap or net worth of $160.12 million as of October 21, 2025. Its market cap has increased by 5,686.78% in one year.
Market Cap
160.12M
Enterprise Value
144.03M
1-Year Change
5,686.78%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since January 4, 2019, China SXT Pharmaceuticals's market cap has increased from $129.31M to $160.12M, an increase of 23.82%. That is a compound annual growth rate of 3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 161.28M | 9,031.39% |
| Dec 31, 2024 | 1.77M | -21.33% |
| Dec 29, 2023 | 2.25M | 54.15% |
| Dec 30, 2022 | 1.46M | -85.57% |
| Dec 31, 2021 | 10.10M | -48.92% |
| Dec 31, 2020 | 19.76M | -10.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |